Metabolic Modeling Identifies a Novel Molecular Type of Glioblastoma Associated with Good Prognosis
Glioblastoma (GBM) is one of the most aggressive forms of cancer. Although IDH1 mutation indicates a good prognosis and a potential target for treatment, most GBMs are IDH1 wild-type. Identifying additional molecular markers would help to generate personalized therapies and improve patient outcomes....
Main Authors: | Qiu Shen, Hua Yang, Qing-Peng Kong, Gong-Hua Li, Li Li |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | Metabolites |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-1989/13/2/172 |
Similar Items
-
Advancing glioblastoma treatment by targeting metabolism
by: Jinyi Zhao, et al.
Published: (2024-05-01) -
A novel score system based on arginine metabolism-related genes to predict prognosis, characterize immune microenvironment, and forecast response to immunotherapy in IDH-wildtype glioblastoma
by: Wentao Feng, et al.
Published: (2023-04-01) -
Glioblastoma: Relationship between Metabolism and Immunosuppressive Microenvironment
by: Ainhoa Hernández, et al.
Published: (2021-12-01) -
Metabolic Abnormalities in Glioblastoma and Metabolic Strategies to Overcome Treatment Resistance
by: Weihua Zhou, et al.
Published: (2019-08-01) -
Metabolic Barriers to Glioblastoma Immunotherapy
by: Nikita Choudhary, et al.
Published: (2023-02-01)